These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 12823079

  • 1. Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder.
    Lepola U, Arató M, Zhu Y, Austin C.
    J Clin Psychiatry; 2003 Jun; 64(6):654-62. PubMed ID: 12823079
    [Abstract] [Full Text] [Related]

  • 2. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
    Keller MB, Gelenberg AJ, Hirschfeld RM, Rush AJ, Thase ME, Kocsis JH, Markowitz JC, Fawcett JA, Koran LM, Klein DN, Russell JM, Kornstein SG, McCullough JP, Davis SM, Harrison WM.
    J Clin Psychiatry; 1998 Nov; 59(11):598-607. PubMed ID: 9862606
    [Abstract] [Full Text] [Related]

  • 3. Chronic depression and comorbid personality disorders: response to sertraline versus imipramine.
    Russell JM, Kornstein SG, Shea MT, McCullough JP, Harrison WM, Hirschfeld RM, Keller MB.
    J Clin Psychiatry; 2003 May; 64(5):554-61. PubMed ID: 12755659
    [Abstract] [Full Text] [Related]

  • 4. Imipramine vs. sertraline in panic disorder: 24-week treatment completers.
    Mavissakalian MR.
    Ann Clin Psychiatry; 2003 May; 15(3-4):171-80. PubMed ID: 14971862
    [Abstract] [Full Text] [Related]

  • 5. Antidepressant efficacy and safety of low-dose sertraline and standard-dose imipramine for the treatment of depression in older adults: results from a double-blind, randomized, controlled clinical trial.
    Forlenza OV, Almeida OP, Stoppe A, Hirata ES, Ferreira RCR.
    Int Psychogeriatr; 2001 Mar; 13(1):75-84. PubMed ID: 11352337
    [Abstract] [Full Text] [Related]

  • 6. Gender differences in treatment response to sertraline versus imipramine in chronic depression.
    Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Davis SM, Harrison WM, Keller MB.
    Am J Psychiatry; 2000 Sep; 157(9):1445-52. PubMed ID: 10964861
    [Abstract] [Full Text] [Related]

  • 7. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
    Thase ME, Fava M, Halbreich U, Kocsis JH, Koran L, Davidson J, Rosenbaum J, Harrison W.
    Arch Gen Psychiatry; 1996 Sep; 53(9):777-84. PubMed ID: 8792754
    [Abstract] [Full Text] [Related]

  • 8. Sertraline treatment of panic disorder: response in patients at risk for poor outcome.
    Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R.
    J Clin Psychiatry; 2000 Dec; 61(12):922-7. PubMed ID: 11206597
    [Abstract] [Full Text] [Related]

  • 9. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.
    Hirschfeld RM, Russell JM, Delgado PL, Fawcett J, Friedman RA, Harrison WM, Koran LM, Miller IW, Thase ME, Howland RH, Connolly MA, Miceli RJ.
    J Clin Psychiatry; 1998 Dec; 59(12):669-75. PubMed ID: 9921701
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
    Lydiard RB, Stahl SM, Hertzman M, Harrison WM.
    J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
    [Abstract] [Full Text] [Related]

  • 11. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
    Mehtonen OP, Søgaard J, Roponen P, Behnke K.
    J Clin Psychiatry; 2000 Feb; 61(2):95-100. PubMed ID: 10732656
    [Abstract] [Full Text] [Related]

  • 12. Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder.
    Nair NP, Bakish D, Saxena B, Amin M, Schwartz G, West TE.
    Anxiety; 1996 Feb; 2(4):192-8. PubMed ID: 9160622
    [Abstract] [Full Text] [Related]

  • 13. Switching from imipramine to sertraline in panic disorder.
    Mavissakalian MR.
    J Psychiatr Pract; 2004 Mar; 10(2):88-94. PubMed ID: 15330404
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antidepressant efficacy of sertraline and imipramine for the treatment of major depression in elderly outpatients.
    Forlenza OV, Stoppe Júnior A, Hirata ES, Ferreira RC.
    Sao Paulo Med J; 2000 Jul 06; 118(4):99-104. PubMed ID: 10887385
    [Abstract] [Full Text] [Related]

  • 18. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients.
    Fabre L, Birkhimer LJ, Zaborny BA, Wong LF, Kapik BM.
    Int Clin Psychopharmacol; 1996 Jun 06; 11(2):119-27. PubMed ID: 8803649
    [Abstract] [Full Text] [Related]

  • 19. The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.
    Rush AJ, Koran LM, Keller MB, Markowitz JC, Harrison WM, Miceli RJ, Fawcett JA, Gelenberg AJ, Hirschfeld RM, Klein DN, Kocsis JH, McCullough JP, Schatzberg AF, Thase ME.
    J Clin Psychiatry; 1998 Nov 06; 59(11):589-97. PubMed ID: 9862605
    [Abstract] [Full Text] [Related]

  • 20. The efficacy of sertraline in panic disorder: combined results from two fixed-dose studies.
    Sheikh JI, Londborg P, Clary CM, Fayyad R.
    Int Clin Psychopharmacol; 2000 Nov 06; 15(6):335-42. PubMed ID: 11110009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.